Cancer is one the most concerning complications of longstanding ulcerative colitis (UC). This study was undertaken to investigate the possible association between eNOS gene intron 4 polymorphism and the development of UC-associated colorectal cancer. It was carried out on 120 subjects; distributed as follows: 40 patients with UC associated colorectal cancer, 40 patients with UC who did not develop colorectal cancer and 40 control subjects. Genotypes (aa, bb, ab) for eNOS gene intron 4 polymorphism were identified using amplified fragment length polymorphism PCR. Plasma nitrate and nitrite levels were used to estimate the amounts of endogenous nitric oxide formation using nitric oxide colorimetric assay kit. Our preliminary data revealed that, compared to the bb genotype, the aa and ab eNOS genotypes were significantly associated with increased risk of developing UC associated colorectal cancer. Meanwhile, in UC associated -colorectal cancer and UC patients groups, plasma NO levels were higher in patients with 4a4a/4a4b genotypes compared to those with bb genotype. It can be concluded from our preliminary
INTRODUCTION
Ulcerative colitis (UC) is a chronic inflammatory disorder of the intestinal tract. Patients with UC frequently experience episodes of bloody diarrhea with or without mucous, abdominal pain, fever and weight loss (Tontini et al., 2015) . Several factors are associated with the initiation and enhancement of chronic inflammatory response in UC including immunologic abnormalities, genetic influences, environmental agents, altered colonic barrier function, bacterial and viral infections as well as nutrition and psychosocial factors (Leone et al., 2013). The development of dysplasia and cancer is one the most concerning complications of longstanding UC (Parian and Lazarev 2015). Thus, noninvasive screening tools that can identify UC patients at high risk for developing colorectal cancer are urgently required. Nitric oxide (NO) is a short-lived, pleiotropic free radical molecule produced by nitric oxide synthase (NOS) enzyme; in a reaction that converts arginine and oxygen into citrulline and NO (Toledo and Augusto 2012). Three isoforms of NOS exist, depending on the site of origin: endothelial (eNOS), neuronal (nNOS), and inducible (iNOS) (Förstermann and Sessa 2012). NO plays a double edged role in modulating the intestinal mucosal integrity; as it can exert both protective and proinflammatory actions. NO, formed physiologically by constitutive NO synthases, regulates vascular tone, protects the microvasculature from injury, and modulates adhesion of inflammatory cells. In contrast, NO has also been associated with the
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initiation and maintenance of inflammation in human inflammatory bowel disease (Lundberg and Weitzberg 2013). The gene encoding eNOS maps to chromosome 7q35-7q36; contains 26 exons with a total size of 21 kb and encodes for a protein of 1203 amino acids (Shankarishan et al., 2014) . The eNOS 4a/b polymorphism of the 27-bp variable number tandem repeats (VNTR) in intron 4 has two alleles: a common large allele and a smaller allele. The larger allele (eNOS4b allele), designated 'b-insertion' has five tandem repeats, and the smaller allele (eNOS4a allele) 'a-deletion' has four repeats (Ekmekçi et al., 2013). This polymorphism been associated with changes in plasma NO levels (Zhang et al., 2008 a) . Several epidemiological studies have investigated the role of eNOS polymorphisms in different types of human cancer including vulvar, prostate, endometrial and breast cancer (Zhang et al., 2014). However; the role of eNOS 4a/b polymorphism in the development of UC-associated colorectal cancer remains to be elucidated. Therefore, we aimed to investigate the possible association between eNOS gene intron 4 polymorphism and the development of UC associated colorectal cancer in order to assess its role as a discriminatory genetic marker for identification of UC patients at high risk for developing cancer.
MATERIALS AND METHODS
This study included eighty ulcerative colitis patients selected from the inpatients and outpatients clinics of the Tropical Medicine Department of Tanta University Hospital, Egypt .They were divided into: forty ulcerative colitis patients with colorectal cancer (18male, 22 female), aged (52.62±7.74) years; besides forty patients with ulcerative colitis without colorectal cancer (15 male, 25 female), aged (49.59± 5.80) years. The diagnosis of UC was based upon a clinical history of Blood sampling: After 12 hours of overnight fasting, 5ml of venous blood samples were taken from each studied subject and kept in EDTA 5% coated tubes. 2.5 ml EDTA treated-blood was separated and stored at -20°C until DNA isolation. Plasma was separated after centrifugation of the other set of EDTA-treated tubes for the NO assay. Routine laboratory investigations were performed for all patients and controls including, complete blood picture, blood urea and serum creatinine, total lipid profile, erythrocyte sedimentation rate and stool examination to exclude bacterial causes of colitis. DNA extraction: Genomic DNA was extracted from the whole blood with EDTA using the GF-1 total DNA Extraction Kit supplied by (Vivantis Inc., CA, USA). DNA purity and concentration were determined spectrophotometrically at 260 and 280 nm. The extracted DNA was stored at -20 °C until analysis. Genotyping for the endothelial nitric oxide synthase intron 4a/b Polymorphism: Polymerase Chain Reaction (PCR) was performed to determine the different genotypes of Endothelial Nitric Oxide Synthase Intron 4a/b Polymorphism. The oligonucleotide primer sequences used were designed according to Ekmekçi et al., 2013 as follows: 5′-AGG CCC TAT GGT AGT GCC TTT-3′ (forward) and 5′-TCT CTT TAG TGC TGT GGT CAC-3′ (reverse). Briefly, the protocol consisted of 35 cycles of DNA denaturation at 95°C for 1 min, primer annealing at 60°C for 45 s and chain extension at 72°C for 1 min, followed by a final extension cycle at 72°C for 5 min. The
constituents of the reaction consisted of: 1.2 µM of each primer, 10 mM of dNTPs, 2 mM of MgCl2, 1 U of Taq DNA polymerase enzyme and 1× PCR buffer, along with 40-50 ng of DNA. The PCR products were separated in a 2% agarose electrophoresis system and the bands were visualized with ethidium bromide staining under ultraviolet (UV) trans-illumination. Two alleles were obtained when this region was amplified: "eNOS4a," which was 393 bp long and consisted of four 27-bp repeating units, and "eNOS4b," which was 420 bp long and consisted of five 27-bp repeating unit. Measurement of plasma total nitrate/nitrite: NO production was determined in a two-step process using nitric oxide colorimetric assay kit (#CAT K262-200, BioVision, CA,USA). In the first step, nitrate was converted to nitrite using nitrate reductase. In the second step, Griess reagents were used to convert nitrite to a deep purple azo compound. The amount of the azo chromophore accurately reflected the amount of NO in the samples. Briefly, 50 µl samples of plasma were mixed with equal volumes of 1% sulfanilamide and 1 mg/ml solution of N-1-naphthyl-ethylenediamine dihydrochloride in 0.5% H3PO4. After 10 min, the absorbance was measured at 540 nm (Giustarini et al., 2008). Statistical analysis: The data were analyzed using statistical package for the social science (SPSS) version 20.0 software (SPSS Inc., Chicago, IL, USA). Frequencies of genotypes/alleles were determined by the gene counting method. Accordance with the Hardy-Weinberg's equilibrium, which indicates an absence of discrepancy between genotype and allele frequencies, was checked using a chi-square goodness-of-fit test. Chi-square tests were used for categorical data and Student's t-tests for continuous data. Multiple comparisons were performed by one-way analysis of variance (ANOVA) followed by Tukey's post-hoc test for multiple comparisons. the significance level of all tests was set at P<0.05.
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RESULTS
The demographic and clinical characteristics of study groups are shown in Table 1 . The differences in distributions of age, sex, BMI, blood pressure and smoking status between the patients and controls were not statistically significant (P >0.05). Three genotypes for eNOS4 a/b polymorphism were recognized by genotyping; homozygous eNOS b/b genotype with one band at 420 bp, homozygous a/a genotype with one band at 393 bp and heterozygous a/b genotype with 2 bands at 420-bp and 393-bp figure (1). The distribution of genotypes of eNOS4 a/b polymorphism in controls were consistent with expectations under the Hardy-Weinberg equilibrium (X 2 =0.21, p=0.64). The genotypic and allelic frequencies of the intron 4a/b eNOS gene polymorphisms in patients and controls are demonstrated in Table 2 . The b/b genotype and the b allele were taken as references. The frequencies of the a/a and a/b eNOS genotypes were significantly higher in UC-CRC patients (20 and 37.5 % respectively) than UC-no CRC patients (5 and 22.5 % respectively) , where the odds ratios for the (a/a, and a/b) genotypes were 6.82 (95% CI : 1.29 -35.92) and 2.84 (95% CI : 1.02-7.88) respectively, p < 0.05. Meanwhile, b/b genotype frequency was significantly lower in UC-CRC patients than UC-no CRC patients (42.5% vs 72.5. %, p < 0.05). Likewise, the frequency of 4a allele was significantly higher in UC-CRC patients (38.75%) than UC-no CRC patients (16.25%), where its odds ratio was 3.26 (95% CI : 1.54-6.86) , p < 0.05 , lending support to the hypothesis that 4a allele might confer an increased risk for the development of UC associated cancer. Furthermore, the a/a and a/b genotypes were significantly higher in UC-CRC patients (20 and 37.5 % respectively) compared to control subjects (2.5 and 20 % respectively), where their odds ratios were 7.29 (95% CI: 1.38 -38.30) and 3.41 (95% CI: 1.2-9.6), respectively, p < Data presented as means± SD or percentage. *P was considered significant at <0.05. CI: confidence interval, * P was considered significant at <0.05. Data are represented as mean ± SD; * significant at p<0.05; a: significant when compared to UC-CRC group, b: significant when compared to UC-no CRC group. 
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DISCUSSION
Our preliminary data pointed out that the (a) variant genotypes of the 4a/4b polymorphism (4b4a+4a4a) were significantly associated with an increased risk of UC -colorectal cancer with reference to the bb genotype, indicating a potentially crucial role for this gene in the development of UC-colorectal cancer. These data are consistent with the findings of Yeh et al. 2009 who suggested that the eNOS 4a allele was associated with a predisposition to early-onset colorectal cancer among a Chinese population in Taiwan. They concluded that the (4b4a+4a4a) eNOS genotypes were associated with a 69% increase in colorectal cancer risk among subjects less than 60 years old, compared with the bb genotype. However, the study by Jang et al. 2013 did not support such an association between the 4a4b polymorphism and colorectal cancer risk in the Korean population. Well in line, several studies have reported that the eNOS 4a allele was positively associated with cancer susceptibility in breast 
